Realbio Group's 18th CACLP/1st CISCE Expo Appointment

Published Time:

2021-03-22

Author:

Source:


Abstract

Time: March 28, 2021 to March 30, 2021 Address: Chongqing International Expo Center (No. 66, Yuelai Avenue, Yubei District)

  Hello! On behalf of Realbio Group, I would like to extend our warmest greetings!

  It is our honor to invite your esteemed company to the 18th China International Congress on Laboratory Medicine and Transfusion Technology (CACLP) and the 1st China International IVD Upstream Raw Materials and Manufacturing Circulation Supply Chain Expo (CISCE), which will be held at the Chongqing International Expo Center (No. 66, Yuelai Avenue, Yubei District) from March 28th to 30th, 2021.

  We would like to invite you and your R&D personnel, production, and procurement staff to visit our booths N7-T049 and N2-S003 for business discussions. If you are interested in further discussions with our technical or business team, please email us at market@realbiogroup.com with your preferred date and time so we can schedule a meeting.

HOT NEWS


Realbio and Thermo Fisher have entered into a strategic partnership to co-build a new ecosystem for localized IVD quality control services.


On May 12, the strategic signing ceremony between Realbio and Thermo Fisher Scientific, a global leader in scientific services, was successfully held at the Thermo Fisher Customer Experience Center in Shanghai. The two parties will engage in in-depth collaboration on "integrated solutions for in-vitro diagnostic quality control materials," jointly embarking on a new chapter of resource sharing and value co-creation. Attendees at the signing ceremony included Patrick Jones, Global President of Professional Diagnostics at Thermo Fisher; Anuj Dhingra, Global Vice President of Professional Diagnostics; Linda Tang, Commercial Director of Professional Diagnostics, China; Luca Saronni, Global Chief Business Development Manager of Clinical Diagnostics; Liangchao Huang, Senior Sales Manager of Clinical Diagnostics, China; Anita Zhang, Product Specialist of Clinical Diagnostics Marketing, China; as well as Su Shaobo, Chairman of Shenzhen Realbio Group; Jiang Wenyu, Deputy General Manager of Operations; and Ji Hongyu, International Business Development Manager. This signing represents not only a joining of hands between the two enterprises but also another significant milestone for Ruiyali in enhancing its local industrial translation capabilities.

2026-05-12

Guangdong Provincial Engineering Technology Research Center for IVD Core Raw Materials (Realbio) Inauguration & Cooperation Signing Ceremony between Shenzhen Realbio Group and Shenzhen CDC


On April 9, Realbio Group and the Shenzhen CDC officially signed a strategic cooperation agreement in Shenzhen. The two parties will engage in in-depth collaboration on the construction of a clinical translation evaluation system for in-vitro diagnostics (IVD), with the aim of bridging the "last mile" from the laboratory to clinical application, enhancing the industry's regulatory market access capabilities, and contributing to the development of a public service platform for the diagnostics field in the Greater Bay Area.

2026-04-10

Realbio Debuts at the 23rd CACLP: Integrated CRO Central Lab Model Accelerates IVD Registration


On March 21, 2026, the 23rd China Association of Clinical Laboratory Practice Expo (CACLP) — the annual bellwether of the IVD industry — grandly opened at the Xiamen International Expo Center. As an enterprise specializing in upstream core raw materials and integrated services for IVD, Realbio made a striking debut with its "CRO New Model for the Full Lifecycle of IVD Registration," demonstrating how, driven by global resource integration and local translation capabilities, it empowers partners to achieve compliant growth, cost reduction, and efficiency gains.

2026-03-23

搜索历史清除全部记录
最多显示8条历史搜索记录噢~
All
  • All
  • Product Management
  • News
  • Introduction
  • Corporate Outlets
  • FAQ
  • Corporate Video
  • Corporate Brochure